JP2006325497A5 - - Google Patents

Download PDF

Info

Publication number
JP2006325497A5
JP2006325497A5 JP2005154985A JP2005154985A JP2006325497A5 JP 2006325497 A5 JP2006325497 A5 JP 2006325497A5 JP 2005154985 A JP2005154985 A JP 2005154985A JP 2005154985 A JP2005154985 A JP 2005154985A JP 2006325497 A5 JP2006325497 A5 JP 2006325497A5
Authority
JP
Japan
Prior art keywords
tick
fragment
prevention
subject
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2005154985A
Other languages
Japanese (ja)
Other versions
JP2006325497A (en
JP4710009B2 (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2005154985A priority Critical patent/JP4710009B2/en
Priority claimed from JP2005154985A external-priority patent/JP4710009B2/en
Publication of JP2006325497A publication Critical patent/JP2006325497A/en
Publication of JP2006325497A5 publication Critical patent/JP2006325497A5/ja
Application granted granted Critical
Publication of JP4710009B2 publication Critical patent/JP4710009B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (2)

請求項1に記載のポリペプチド若しくはその断片、請求項2に記載のポリヌクレオチド、又は請求項3に記載のベクターを、マダニ駆除の必要な対象に、有効量で投与することを含む、動物(ヒトを除く)におけるマダニ駆除方法。 An animal comprising administering the polypeptide according to claim 1 or a fragment thereof, the polynucleotide according to claim 2 or the vector according to claim 3 to a subject in need of tick control in an effective amount. Tick control method in (except human) . 請求項1に記載のポリペプチド若しくはその断片、請求項2に記載のポリヌクレオチド、又は請求項3に記載のベクターを、マダニ媒介性感染症の治療又は予防の必要な対象に、有効量で投与することを含む、動物(ヒトを除く)におけるマダニ媒介性感染症の治療又は予防方法。 An effective amount of the polypeptide according to claim 1 or a fragment thereof, the polynucleotide according to claim 2, or the vector according to claim 3 to a subject in need of treatment or prevention of a tick-borne infection. A method for the treatment or prevention of tick-borne infections in animals (excluding humans) .
JP2005154985A 2005-05-27 2005-05-27 Tick aspartic protease Active JP4710009B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2005154985A JP4710009B2 (en) 2005-05-27 2005-05-27 Tick aspartic protease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005154985A JP4710009B2 (en) 2005-05-27 2005-05-27 Tick aspartic protease

Publications (3)

Publication Number Publication Date
JP2006325497A JP2006325497A (en) 2006-12-07
JP2006325497A5 true JP2006325497A5 (en) 2008-05-01
JP4710009B2 JP4710009B2 (en) 2011-06-29

Family

ID=37547862

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005154985A Active JP4710009B2 (en) 2005-05-27 2005-05-27 Tick aspartic protease

Country Status (1)

Country Link
JP (1) JP4710009B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009508862A (en) * 2005-09-16 2009-03-05 ユニバーシティ オブ コネチカット Acaricidal composition and method of use
CN108893458A (en) * 2018-07-19 2018-11-27 中国农业科学院饲料研究所 Acid protease Bs2688 and its gene and application

Similar Documents

Publication Publication Date Title
WO2004103208A3 (en) Manufacture and use of implantable reticulated elastomeric matrices
DK2042036T3 (en) Mite composition, use thereof, method for breeding the phytoside prey mite Amblyseius Swirskii, breeding system for breeding said phytoside mite and methods for biological pest control on crop
ATE453642T1 (en) SUBSTITUTED PHENYLAMINOPYRIMIDINES
DK1534335T3 (en) FcgammaRIIB-specific antibodies and methods for their use
JP2005518433A5 (en)
JP2009526751A5 (en)
BRPI1009860A2 (en) compound, use thereof, pharmaceutical composition and method for the therapeutic treatment or prevention of disease in humans or animals
ATE464890T1 (en) A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PATHOLOGIES CAUSED BY THE GENERAL IMMUNE RESPONSE
DK2079481T3 (en) Vaccine peptide combinations against cat allergy
EA201100413A1 (en) METHOD OF TREATING BACTERIAL INFECTION
WO2007126363A3 (en) Antisecretory protein for use in the treatment of compartment syndrome
WO2007009701A3 (en) Use of substituted pyrazole compounds and combinations thereof for the treatment of the metabolic syndrome
WO2006046017A3 (en) Vaccine and nucleic acids capable of protecting poultry against colonisation by campylobacter
WO2006119983A3 (en) Genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy
EA200601533A1 (en) Antifungal peptides
WO2007009686A3 (en) Substituted pyrazoline compounds, their preparation and use as medicaments
WO2008097364A3 (en) Use of oritavancin for prevention and treatment of anthrax
WO2008017636A8 (en) Genes and proteins of brachyspira hyodysenteriae and uses thereof
JP2006325497A5 (en)
WO2004110466A3 (en) Pediocin-producing pediococci
WO2007107323A8 (en) Novel genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy
JP2007259804A5 (en)
RU2006109966A (en) YANTASTIM-S DRUG FOR THERAPY AND PREVENTION OF ANIMAL INFECTIOUS DISEASES
JP2005523891A5 (en)
WO2008033477A3 (en) Antimicrobial activity in variants of lacritin